CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Filters
3 research outputs found
Author response for "Pharmacokinetic and Pharmacodynamic Bioequivalence of Proposed Biosimilar MYL‐1501D With US and EU Insulin Glargine Formulations in Patients With Type 1 Diabetes Mellitus"
Author
null Abhijit Barve
null Charles Donnelly
null Patrick Aubonnet
null Tim Heise
Publication venue
Wiley
Publication date
01/11/2019
Field of study
No full text
Crossref
Author response for "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in Patients With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study"
Author
null Abhijit Barve
null Bin Sun
+5 more
null Patrick Aubonnet
null Rafael Muniz
null Sandeep Athalye
null Thomas C. Blevins
null Yaron Raiter
Publication venue
Wiley
Publication date
18/10/2019
Field of study
No full text
Crossref
New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies
Author
Anna Lochocka
Axel Schaeffer
+8 more
Cesar Gonzalo Calvo Vargas
Christelle Foucher
Dmitry Belenky
Hans-Friedrich Koch
Mario Berli
null null
Patrick Aubonnet
Petr Reichert
Publication venue
Wiley
Publication date
02/11/2015
Field of study
Full text link
Crossref